Back

The predictive role of left ventricular cathode topography relative to CMR-determined latest mechanical activation and scar segments on response to cardiac resynchronisation therapy.

28 August 2023 (17:05 - 17:15)
Organised by: Logo
Congress Presentation Part of: Recent insights into cardiac resynchronisation therapy and device complications Cardiac Resynchronisation Therapy (CRT) ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Michele Bertelli

University Hospital of Bologna S. Orsola-Malpighi Polyclinic, Bologna (Italy)

5 More presentations in this session

Presentation thumbnail
Activation time at left ventricular pacing site (QLV) in relation to actual site of latest activation; effect on response to cardiac resynchronization therapy
Doctor L. Parreira (Setubal, PT)
Abstract Slides Video
Presentation thumbnail
Risk factors and prognostic implications for new-onset heart failure with ventricular pacing - a nationwide study
Doctor F. Maiwand (Lund, SE)
Abstract Slides Video
Presentation thumbnail
Clinical outcomes of left bundle branch area pacing compared with biventricular pacing in patients with heart failure requiring cardiac resynchronization therapy: systematic review and meta-analysis
Doctor G. Leventopoulos (Patras, GR)
Abstract Slides Video
Presentation thumbnail
Complications according to intrathoracic versus extrathoracic venous access for cardiac device implantation: results from the PLACE (Planning Lead Access for Cardiac Electrostimulation) study
Doctor C. Ghiglieno (Rivoli, IT)
Abstract Slides
Presentation thumbnail
Contemporary management and awareness of cardiac implantable electronic device infection: a European survey
Professor J. Weil (Luebeck, DE)
Abstract Slides

Access the full session

Session thumbnail
Recent insights into cardiac resynchronisation therapy and device complications
Video

The Event

Event poster

ESC Congress 2023

28 August 2023 17:05 CET
You may be interested in
thumbnail
Congress Presentation
Activation time at left ventricular pacing site (QLV) in relation to actual site of latest activation; effect on response to cardiac resynchronization therapy
thumbnail
Congress Session
Recent insights into cardiac resynchronisation therapy and device complications
thumbnail
Congress Session
Fighting ventricular dyssynchrony: cardiac resynchronisation therapy vs. conduction-system pacing

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources